1. Home
  2. VITL vs EIKN Comparison

VITL vs EIKN Comparison

Compare VITL & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vital Farms Inc.

VITL

Vital Farms Inc.

N/A

Current Price

$8.92

Market Cap

557.9M

ML Signal

N/A

Logo Eikon Therapeutics Inc. Common Stock

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$7.53

Market Cap

631.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VITL
EIKN
Founded
2007
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
557.9M
631.0M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
VITL
EIKN
Price
$8.92
$7.53
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$13.22
★ $24.60
AVG Volume (30 Days)
★ 1.5M
518.4K
Earning Date
11-03-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 22.03
N/A
EPS
★ N/A
N/A
Revenue
★ $759,444,000.00
N/A
Revenue This Year
$1.33
N/A
Revenue Next Year
$7.03
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 25.26
N/A
52 Week Low
$7.95
$7.55
52 Week High
$45.16
$16.50

Technical Indicators

Market Signals
Indicator
VITL
EIKN
Relative Strength Index (RSI) 35.31 35.89
Support Level $7.95 N/A
Resistance Level $13.83 $10.20
Average True Range (ATR) 0.60 0.64
MACD -0.13 -0.09
Stochastic Oscillator 7.94 12.80

Price Performance

Historical Comparison
VITL
EIKN

About VITL Vital Farms Inc.

Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).

About EIKN Eikon Therapeutics Inc. Common Stock

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Share on Social Networks: